our facilities are powered by renewable energy sources
PLF Pharma is the trading name for Hempire Limited, a UK owned and registered company. Operating from a purpose built facility in the UK the company is committed to developing consistently high quality cannabis based medicinal products.
Since 2015, three years before medical cannabis was legalised in the UK, PLF Pharma has been focused on providing responsibly produced medical cannabis products to euGMP standards. PLF Pharma work closely with the NHS, Kings College London and other partners to build a framework that allows the company to produce the highest quality active pharmaceutical ingredients to help shape the future of medicinal cannabis in the UK and to reduce the friction during patient access.
Together with our strategic partners, our primary focus is to develop, produce and distribute medicinal products to consistent standards of quality, safety and efficacy. Through clinical trials, research and operating ethics, we aim to develop and manufacture industry leading medicinal products for patients with an unmet need.
Our Facility
PLF Pharma has a carbon neutral facility in the north of England powered by two 600KW wind turbines and a 30KW array of photovoltaic panels.
This will serve as a model for larger, environmentally sustainable facilities moving forward as part of our phased expansion.
This will be the first carbon neutral, euGMP cultivation and post processing facility in Europe.
Board Members
Karl Spratt
Co Founder & CEO
A 34 year veteran in crafting multi million pound businesses in design, property, renewable energy and now medicinal cannabis. A forward-thinking strategist with an acute sense for emerging markets. This leaders track record speaks volumes. Now on a journey where vision, innovation and a proven history converge to create another successful business.
Paul Kirkham
Co Founder & Director
Bringing over 30 years of invaluable expertise from within the health and beauty Industry. His career features senior management positions with Industry giants such as Wella, P&G and Coty, with a proven track record of success. Paul has consistently demonstrated exceptional leadership and strategic acumen, making him a trusted and accomplished professional in this field.
Steve Grady
Director
Steve is a co founder of a company that supplies web solutions to local authorities. He also acts as a consultant to several UK companies and brings a wealth of marketing, Digital infrastructure, communications, IT and manufacturing efficiency experience to the board.
Charles Calvert
Director
Experienced in financial services both in the UK and Middle East. An investor in various sectors both as an Angel and consul- tant. Charles has also enjoyed success in property development. With his multi sector networking and entrepreneurial energy he is accustomed to working within highly regulated industries and undoubtedly adds value and drive to the board.
Advisory Board
Dr. Burrinder Grewal
Advisor
Currently Managing Director of NHS Huddersfield Pharmacy Specials, who develop and manufactures medicines that are distributed throughout the NHS. He holds degrees in Pharmacy and Economics and a doctorate in Transdermal Drug Delivery and formulation.
Peter Ridgway
Advisor
Specialising in chromatography and purification. Working in the pharmaceutical industry for over 25 years with AstraZeneca Peter is a director of Reach Separations Peter graduated in Chemistry from Nottingham Trent University. Until 2018 Peter was a visiting Lecturer at
Kings College London .
Dr. Callie Seaman BSc (HONS)
Advisor
Co-Chair of the Cannabis Industry Council, plant scientist and formulation chemist, working with international cannabis companies as a director and researcher. She has worked for GlaxoSmithKline on drug metabolism and pharmacokinetics
Tim Hugo
Advisor
Consultant to UK private companies.. Providing support to help identify the key strategic opportunities and overcome the technical challenges that businesses face today. Tim worked in the City in the Capital Markets Division (DCM and ECM) at a senior management level for a number of leading investment banks.
Dan Gulliver
Advisor
Owner Director of First Cross Consultancy with over 16 years-experience in the indoor horticulture sector, Working around the globe creating full client journey’s from facility design, R&D stage testing, installation, creation and implementation of SOP’s, Working with some of the most respected names in the industry, Dan has a strong network of global contacts
